PharmaVOICE - 
October 2008
Purchase Issue

In Every Issue
Last Word
Leonard Bell, M.D.,CEO of Alexion, is also the Principal Founder [...]
By
Talent Pool
Pharma POOL Mark GLICKMAN Oscient Promotes Sales Executive Commercial stage [...]
By
On the Calendar
October 15 3rd Leadership Summit on Medicare Enrollment and PDE [...]
By
E-Media
NEW ELECTRONIC AND WEB BASED APPLICATIONS, SITES, AND TECHNOLOGIES inVentiv [...]
By
What’s New
NEW HEALTH CARE RELATED PRODUCTS, SERVICES, AND COMPANIES Julie Kampf [...]
By
PharmaTrax
Cubist Pharmaceuticals’ Cubicin (daptomycin), the first of the cyclic lipopeptides [...]
By
PharmaOutlet
Listen to the debates on Capitol Hill about DTC advertising [...]
By

David Levin

UpFront
VOTE 2008 Healthcare Among Top Concerns TNS Healthcare reveals that [...]
By
Raise Your Voice: Letters
Mobile Marketing The May article “At the End of the [...]
By
Letter from the Editor
Business not as usual. This month’s Forum — Virtual Pharma: [...]
By

Taren Grom, Editor

On The Cover

Virtual Pharma: Cheaper and Faster, but Doable?
BY ROBIN ROBINSON More and more science-based projects are being shared across silos, networks, and organizations. At the same time, biomedical knowledge is expanding rapidly, but the existing drug-discovery process is unable to keep pace. The industry needs to fix what is broken, and the solution, our experts say, is in the evolution of a [...]
By

Robin Robinson

Features

People are Talking Behind Your (Brand’s) Back! … And That’s Great News
Compass Healthcare Communications
By
8th Annual PharmaLinx Charity Golf Outing
Raising More than ,000 for the Lankenau Institute for Medical Research Hosted by PharmaLinx LLC, publisher of PharmaVOICE Magazine We Extend Thanks to These Companies for Their Contributions GOLD CORPORATE SPONSORS Gallagher Benefits Services Inc. J. Knipper and Company Inc. BRONZE CORPORATE SPONSORS CommonHealth Proprint PUTTING COMPETITION SPONSOR Thomson Reuters LUNCH SPONSOR Excerpta Medica REFRESHMENT [...]
By
Sales Training for Managed Markets
Today’s pharmaceutical environment is dominated by managed markets. And sales training programs have to evolve to address the special needs of these special markets. While sales representatives have a strong knowledge of the clinical aspects of their products, they may have a harder time being able to address the economics of managed markets. “Oftentimes, the [...]
By

Denise Myshko

New Requirements for Advisory Meetings Provide New Opportunities
This past decade has brought increased focus and attention to pharmaceutical company interactions with healthcare providers regarding marketed products. Further to the 1992 AMA Guidelines on Gifts to Physicians from Industry, pharma marketers must now take into consideration the PhRMA Code on Interactions with Healthcare Professionals and the OIG Compliance Program Guidance for Pharmaceutical Manufacturers. [...]
By

Joan Bradley

Joe Jimenez: Straightforward and Consumer Focused
BY KIM RIBBINK COMPLETE The Package With an ability to step back from the protracted machinations that often prevail at pharma companies, is leading Novartis with a focus on the customer and a commitment to meeting goals and priorities. JOE Jimenez Sometimes it’s the simplest observations that help illuminate answers to the most complex issues. [...]
By

Kim Ribbink

Life After the Focus Group
BY ROBIN ROBINSON IS THE FOCUS GROUP DEAD OR JUST DECLINING? While some people say the focus group is dead, others say it will never entirely disappear. Their opinions hinge on what position they hold in the market research process and what objective the research is trying to meet (turn to page 32). Six years [...]
By

Robin Robinson

Generics Looming Larger Than Ever
As generic companies continue to expand and consolidate, they are likely to step up their efforts to explore options for developing products beyond chemical equivalents, moving into specialty generics, bio generics, and proprietary molecules. As a result, the generics market is fast becoming a worldwide phenomenon. “There used to be four big generic markets: the [...]
By

Denise Myshko

FEEDBACK